MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss applicable
to common...
-$5,887,830
Net loss
-$4,512,642
Dividend attributable to
series a, b, and c...
$1,375,188
Loss from operations
-$3,840,244
Total other expense
-$672,398
Change in fair value of
derivative...
$353,174
Change in fair value of
derivative...
$44,835
Gain on
extinguishment of note payable
$17,893
Total operating
expenses
$3,840,244
Interest
expense-Related Party
$651,910
Interest expense -
amortization of debt...
$156,221
Interest expense -
amortization of debt...
$153,693
Interest
expense-Nonrelated Party
$126,476
General and
administrative
$1,942,163
Research and
development-Nonrelated Party
$1,840,081
Research and
development-Related Party
$58,000
Back
Back
Income Statement
source: myfinsight.com
Cell Source, Inc. (CLCS)
Cell Source, Inc. (CLCS)